Cargando…

Etiology and Management of Bleeding during ECMO in a COVID-19 Patient

Detalles Bibliográficos
Autores principales:	Yamada, Shinya, Ogawa, Haruhiko, Asakura, Hidesaku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147565/ https://www.ncbi.nlm.nih.gov/pubmed/33487607 http://dx.doi.org/10.5551/jat.61747

Ejemplares similares

Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Response to “Etiology and Management of Bleeding during ECMO in a COVID-19 Patient”
por: Hayakawa, Masaki, et al.
Publicado: (2021)

COVID-19-associated coagulopathy and disseminated intravascular coagulation
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Potential of heparin and nafamostat combination therapy for COVID‐19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
por: Yamada, Shinya, et al.
Publicado: (2022)

Cytokine adsorption and ECMO in patients with COVID-19
por: Rybalko, Andrey, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19
por: Nardelli, Pasquale, et al.
Publicado: (2021)

Blood transfusion strategies and ECMO during the COVID-19 pandemic
por: Koeckerling, David, et al.
Publicado: (2020)

Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm
por: Yamada, Shinya, et al.
Publicado: (2022)

Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply
por: Supady, Alexander
Publicado: (2021)

Contrast Echocardiography in VV-ECMO-Dependent Patients with COVID-19
por: Bleakley, Caroline, et al.
Publicado: (2020)

ECMO support for COVID-19: a balancing act
por: Zhang, Yang, et al.
Publicado: (2021)

COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020)

The Dilemma in the Management of Gastrointestinal Bleeding During the COVID-19 Pandemic
por: Aguila, Enrik John T., et al.
Publicado: (2021)

ECMO and CRRT “All in One!” in COVID-19 Era
por: Condello, Ignazio, et al.
Publicado: (2023)

Determinants of long-term outcomes in patients with COVID-19 supported with ECMO
por: Guervilly, Christophe, et al.
Publicado: (2023)

The need to define “who” rather than “if” for ECMO in COVID-19
por: Whebell, Stephen, et al.
Publicado: (2022)

Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation
por: Takahashi, Wakana, et al.
Publicado: (2021)

ECMO support for COVID-19: a balancing act – Authors' reply
por: Barbaro, Ryan P, et al.
Publicado: (2021)

Determinants of long-term outcomes in patients with COVID-19 supported with ECMO – Authors' reply
por: Lorusso, Roberto, et al.
Publicado: (2023)

Blue Rubber Bleb Nevus Syndrome Complicated by Enhanced-Fibrinolytic-Type DIC: A Case Report
por: Yamada, Shinya, et al.
Publicado: (2021)

VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations
por: Hoyler, Marguerite M., et al.
Publicado: (2020)

Thrombolysis for ECMO oxygenator thrombosis
por: Taccone, Fabio Silvio, et al.
Publicado: (2023)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey
por: Iba, Toshiaki, et al.
Publicado: (2014)

Unique meteorological characteristics in the upper gastrointestinal bleeding by different etiologies in Beijing Area, China
por: Yuan, Yue, et al.
Publicado: (2021)

Anticoagulation Management in High Bleeding-Risk ECMO in Adults
por: De Paulis, Stefano, et al.
Publicado: (2022)

Magnetic levitation pumps for cell-free hemoglobin prevention during VV ECMO
por: Condello, Ignazio
Publicado: (2022)

Recombinant human erythropoietin attenuates hepatic dysfunction by suppressing hepatocellular apoptosis in lipopolysaccharide-induced disseminated intravascular coagulation in rats
por: Suga, Yukio, et al.
Publicado: (2022)

Myocardial infarction due to malposition of ECMO cannula
por: Reis Miranda, Dinis, et al.
Publicado: (2012)

Improved Strategies for ECMO in the Setting of Renal Failure
por: Jacobs, Jeffrey Phillip, et al.
Publicado: (2023)

Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: “perceived futility” and potential underestimation of ECMO’s effect
por: Watanabe, Atsuyuki
Publicado: (2022)

Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
por: Hayanga, J. W. Awori
Publicado: (2023)

Bleeding During Veno-Venous ECMO: Prevention and Treatment
por: Kalbhenn, Johannes, et al.
Publicado: (2022)

Hidden Harlequin syndrome in neonatal and pediatric VA-ECMO
por: Levy, Yael, et al.
Publicado: (2022)

Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service
por: Camporota, Luigi, et al.
Publicado: (2021)

Postcardiotomy VA ECMO in adult patients: Italian single center experience in 2021
por: L’Acqua, Camilla, et al.
Publicado: (2022)

PAP Therapy Compliance in COVID-19: Multifactorial Etiologies to Consider
por: Rathi, Vidushi, et al.
Publicado: (2023)

Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
por: Yamada, Shinya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_peipp941vrt6cmun6bn9v350bt